OBJECTIVE	To compare the efficacy , safety , and tolerability of 6 dosages of oral tofacitinib ( CP-690 ,550 ) with placebo for the treatment of active rheumatoid arthritis ( RA ) in patients receiving a stable background regimen of methotrexate ( MTX ) who have an inadequate response to MTX monotherapy .\